US biopharma: "nearly 300 vaccines in R&D"

Article Date: 24/04/2012 06:00
US biopharma: "nearly 300 vaccines in R&D"

Vacancy Search

Quick job search

Advanced Search

Latest News

UPDATED: J&J buys Alios for $1.75 billion

UPDATED: J&J buys Alios for $1.75 billion

Pfizer inks immunotherapy combo pact with Japan's KHK

Pfizer inks immunotherapy combo pact with Japan's KHK

UPDATED: PM guarantees seven-days-a-week GP access

UPDATED: PM guarantees seven-days-a-week GP access

Chiltern PCR buy cements Asia-Pacific offering

Chiltern PCR buy cements Asia-Pacific offering

Over 700 biosimilars now in development worldwide: report

Over 700 biosimilars now in development worldwide: report

Amag $1 billion deal to buy preterm birth drug Makena

Amag $1 billion deal to buy preterm birth drug Makena

NHS first with unique stem cell storage deal

NHS first with unique stem cell storage deal

Horizon is world leader in gene-editing with Sage buy

Horizon is world leader in gene-editing with Sage buy

NHS Innovation Challenge to focus on diabetes

NHS Innovation Challenge to focus on diabetes

Daiichi Sankyo set to acquire Ambit in $410 million deal

Daiichi Sankyo set to acquire Ambit in $410 million deal
more news